Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 53.05
+3.75 (7.61%)
May 7, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 42.51 billion as of May 7, 2026. Its market cap has increased by 759.67% in one year.
Market Cap
42.51B
Enterprise Value
42.24B
Revenue
1.78B
Ranking
n/a
PE Ratio
60.54
Stock Price
53.05
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 42.51B, an increase of 312.13%. That is a compound annual growth rate of 46.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 42.42B | 79.84% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 97.15B |
| RemeGen | 72.64B |
| 3SBio | 55.76B |
| Shanghai Junshi Biosciences | 41.95B |
| Shanghai Henlius Biotech | 40.63B |
| Genscript Biotech | 29.69B |
| InnoCare Pharma | 27.77B |
| Duality Biotherapeutics | 24.31B |